ABIO - ARCA Bio Quarterly EPS earnings growth

ARCA Bio - graphic logo of issuer ABIO

ARCA Biopharma focuses on developing precision cardiovascular drugs, utilizing genetic methods to achieve monopoly pricing power. The team relies on an academic approach and an option system to retain biochemists. Current expectations regarding the asset merger are already priced in by the market. The quarterly EPS trend reflects the business's fundamental value, with the parameter mark equal to -80.20, which helps filter out random market noise.

ARCA Biopharma, Inc. (ABIO) - Year-over-year net earnings per share change for the last twelve months from 07/04/2022 to 09/03/2024

Analytical breakdowns for arcabio.com (ABIO)

- share price and consensus valuation forecast:
Summary company analytics:ARCA Bio - ABIO
Manufactured product of ARCA Biopharma

Outsourcing production and testing to third-party contractors allows ARCA Biopharma (ABIO) to optimize costs, which directly impacts net profit dynamics. By analyzing comparable quarterly EPS growth, investors track the mathematical rate of change in earnings per share to determine the efficiency of the business model and eliminate emotional bias when analyzing the liquidity and fundamental stability of this asset.

Competitor analysis

Regeneron Pharmaceuticals (REGN) - Year-over-year earnings per share growth for the last twelve months|IRTC: Year-over-year earnings per share growth rate for the last twelve months|LNTH (Lantheus Holdings) - Quarterly EPS earnings growth|Quarterly EPS earnings growth mineralystx.com|Year-over-year earnings per share growth for the last twelve months HeartFlow Inc (HTFL)|KMTS (Kestra Medical Technologies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Esperion Therapeutics ESPR|AMRN - Year-over-year net earnings per share growth for the last 12 months|Anteris Technologies Ltd - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TNYA (tenayatherapeutics.com)|CVRX: Quarterly EPS earnings growth|Milestone Pharmaceuticals, Inc. - Year-over-year earnings per one share growth for the last 12 months|CRDL (Cardiol Therapeutics Inc) - Quarterly EPS earnings growth|HeartBeam Corporation (BEAT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tenax Therapeutics, Inc (TENX)|Year-over-year net earnings per share growth for the last 12 months Adagio Medical Holdings ADGM|Quarterly EPS earnings growth BCDA (BioCardia Inc.)|VTAK - Year-over-year net earnings per share growth for the last 12 months|Acasti Pharma - Quarterly EPS earnings growth|AVTE - Quarterly EPS earnings growth|VERV (vervetx.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share trend for the last twelve months WINT (Windtree Therapeutics Inc.)